Enron
Kunshan · Founded 2023
About Enron
Enron focusing on the research and development of innovative drugs that regulate the secretion of neurotransmitters.
Company Facts
- Founded: 2023
- Legal name: Enron Pharmaceuticals (Kunshan) New Drug Development Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Apr 2025)
Canonical: https://fsome.com/organization/enron-8432608 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.